NIH-funded research NIH-funded research

Understanding how oxidative stress affects DNA replication and stability

Official title: Investigating the Cellular Impact of 8-oxo-Guanine on DNA Replication and Genome Stability

Funded at University of Kansas Medical Center · NIH-10977080 · Data updated 2026-11-12

This study is looking at how oxidative stress can harm DNA, especially a specific type of damage called 8-oxodeoxyguanosine, using a new method that lets researchers control this damage in living cells, which could help us understand how it relates to cancer and aging.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Kansas Medical Center
NIH-funded
Lab location1 site (Kansas City, United States)
Project startNovember 1, 2023
Project endOctober 31, 2026
Funding year2025
Award (this year)$249,000
NIH project number5R00ES033771-04
Project IDNIH-10977080 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at risk for conditions associated with oxidative stress, including certain cancers and age-related diseases.

Less likely to help

Patients with conditions unrelated to oxidative stress or DNA damage may not benefit from this research.

What this research studies

This research investigates the effects of oxidative stress on DNA, particularly focusing on a specific DNA damage known as 8-oxodeoxyguanosine (8oxoG). The team has developed a novel method using a chemoptogenetic system that allows for precise control over the production of 8oxoG in living cells. By using a specialized peptide that binds to a photosensitizer dye, they can generate singlet oxygen, which specifically damages guanine in DNA. This approach aims to provide insights into how oxidative stress impacts DNA replication and contributes to genomic instability, which is crucial for understanding cancer development and aging.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating conditions related to DNA damage, such as cancer.

How similar studies have gone: Previous research has shown promising results in understanding DNA damage mechanisms, but this specific approach using the chemoptogenetic system is relatively novel.

Where this research is happening

  • University of Kansas Medical Center
    Kansas City, United States
    Active

Researchers

  • Principal investigator: Barnes, Ryan P — University of Kansas Medical Center
  • Study coordinator: Barnes, Ryan P

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.